Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy (eBook, PDF)
Redaktion: Kalinski, Pawel
97,95 €
97,95 €
inkl. MwSt.
Sofort per Download lieferbar
49 °P sammeln
97,95 €
Als Download kaufen
97,95 €
inkl. MwSt.
Sofort per Download lieferbar
49 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
97,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
49 °P sammeln
Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy (eBook, PDF)
Redaktion: Kalinski, Pawel
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Sheds light on the mechanisms, factors, and mediators that are involved in the dynamic cancer cell environment
Volume explores the bi-directional interactions between tumor cells and non-malignant tumor component during tumor progression and treatment
Focuses on the three groups of the reactive tumor component: stromal cells, blood vessels and the infiltrating immune cells
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Größe: 8.16MB
Andere Kunden interessierten sich auch für
- Tumor Microenvironment (eBook, PDF)113,95 €
- Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers (eBook, PDF)113,95 €
- Programmed Cell Death in Cancer Progression and Therapy (eBook, PDF)161,95 €
- Tumor Microenvironment (eBook, PDF)65,95 €
- Hypoxia and Tumor Microenvironment (eBook, PDF)169,95 €
- Tumor Microenvironment and Cellular Stress (eBook, PDF)161,95 €
- Hypoxia and Cancer (eBook, PDF)113,95 €
-
-
-
Sheds light on the mechanisms, factors, and mediators that are involved in the dynamic cancer cell environment
Volume explores the bi-directional interactions between tumor cells and non-malignant tumor component during tumor progression and treatment
Focuses on the three groups of the reactive tumor component: stromal cells, blood vessels and the infiltrating immune cells
Volume explores the bi-directional interactions between tumor cells and non-malignant tumor component during tumor progression and treatment
Focuses on the three groups of the reactive tumor component: stromal cells, blood vessels and the infiltrating immune cells
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Springer Nature Switzerland
- Seitenzahl: 264
- Erscheinungstermin: 22. Dezember 2017
- Englisch
- ISBN-13: 9783319675770
- Artikelnr.: 53061160
- Verlag: Springer Nature Switzerland
- Seitenzahl: 264
- Erscheinungstermin: 22. Dezember 2017
- Englisch
- ISBN-13: 9783319675770
- Artikelnr.: 53061160
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Pawel Kalinski, M.D., Ph.D., is the Vice Chair for Translational Research and Professor of Oncology in the Department of Medicine at Roswell Park Cancer Institute (RPCI) in Buffalo, NY. He is also the Director of Cancer Vaccine and Dendritic Cell Therapies in the Center for Immunotherapy, and a Co-Leader of the Tumor Immunology & Immunotherapy Program of RPCI. Dr. Kalinski is a member of the Society for Immunotherapy of Cancer (SITC), American Association of Immunologists (AAI), American Association for Cancer Research (AACR) and the American Society of Clinical Investigation (ASCI) and an editorial board member of several journals in the area of cancer immunology and immunotherapy. He has been the recipient of multiple grants from the National Cancer Institute in recent years. Dr. Kalinski has published over 130 papers in the areas of immunology and cancer research and has been cited over 5,500 times.
Part 1. Interplay Between Tumor Cells, Stroma and Inflammatory Infiltrate in Regulating Tumor Micro-Environment.- Tumor Immuno-Environment in Cancer Progression and Therapy.- Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment.- Regulation of CTL Infiltration Within the Tumor Microenvironment.- The Role of Tumor Microenvironment in Cancer Immunotherapy.- Part 2. Mediators of Tumor Microenvironment.- Immunogenic and Non-Immunogenic Cell Death in the Tumor Microenvironment.- Exosomes in Cancer: Another Mechanism of Tumor-Induced Immune Suppression.- Chemo-immunotherapy: Impact of Indoleamine 2,3-dioxygenase in Defining Immunogenic versus Tolerogenic Cell Death in the Tumor Microenvironment.- Targeting Myeloid-Derived Suppressor Cells in Cancer.- Tryptophan catabolism and cancer immunotherapy targeting IDO mediated immune Suppression.- Part 3. Emerging Targets and Technologies of Modulation of Tumor Microenvironment.- Tumor Microenvironment in Cancer Progression and Therapy.- The Role of the Immune System and Immunoregulatory Mechanisms Relevant to Melanoma.- Oncolytic Virotherapy and the Tumor Microenvironment.- The Impact of Housing Temperature Induced Chronic Stress on Preclinical Mouse Tumor Models and Therapeutic Responses: An Important Role for the Nervous Role for the Nervous System.- (Immuno)therapeutic Targeting of Tumor-Associated Blood Vessels.- Adaptive Resistance to Cancer Immunotherapy.- Imaging the Tumor Microenvironment.
Part 1. Interplay Between Tumor Cells, Stroma and Inflammatory Infiltrate in Regulating Tumor Micro-Environment.- Tumor Immuno-Environment in Cancer Progression and Therapy.- Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment.- Regulation of CTL Infiltration Within the Tumor Microenvironment.- The Role of Tumor Microenvironment in Cancer Immunotherapy.- Part 2. Mediators of Tumor Microenvironment.- Immunogenic and Non-Immunogenic Cell Death in the Tumor Microenvironment.- Exosomes in Cancer: Another Mechanism of Tumor-Induced Immune Suppression.- Chemo-immunotherapy: Impact of Indoleamine 2,3-dioxygenase in Defining Immunogenic versus Tolerogenic Cell Death in the Tumor Microenvironment.- Targeting Myeloid-Derived Suppressor Cells in Cancer.- Tryptophan catabolism and cancer immunotherapy targeting IDO mediated immune Suppression.- Part 3. Emerging Targets and Technologies of Modulation of Tumor Microenvironment.- Tumor Microenvironment in Cancer Progression and Therapy.- The Role of the Immune System and Immunoregulatory Mechanisms Relevant to Melanoma.- Oncolytic Virotherapy and the Tumor Microenvironment.- The Impact of Housing Temperature Induced Chronic Stress on Preclinical Mouse Tumor Models and Therapeutic Responses: An Important Role for the Nervous Role for the Nervous System.- (Immuno)therapeutic Targeting of Tumor-Associated Blood Vessels.- Adaptive Resistance to Cancer Immunotherapy.- Imaging the Tumor Microenvironment.